Dov Kadmon
Overview
Explore the profile of Dov Kadmon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
830
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tahir S, Yang G, Goltsov A, Watanabe M, Tabata K, Addai J, et al.
Cancer Res
. 2008 Feb;
68(3):731-9.
PMID: 18245473
Caveolin, a major structural component of specialized plasma membrane invaginations (caveolae) that participate in diverse cellular activities, has been implicated in the pathogenesis of several human diseases, including cancer. We...
12.
Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles B, et al.
Hum Pathol
. 2008 Jan;
39(2):282-91.
PMID: 18206496
We previously reported that reactive stromal grading in radical prostatectomies is a predictor of recurrence and that reactive stromal grading 0 and 3 are associated with lower biochemical recurrence-free survival...
13.
Sonpavde G, Chi K, Powles T, Sweeney C, Hahn N, Hutson T, et al.
Cancer
. 2007 Oct;
110(12):2628-39.
PMID: 17941029
The results of this assessment of the literature indicated that neoadjuvant therapy followed by prostatectomy may improve long-term outcomes for patients with high-risk localized disease. In addition, this approach provides...
14.
Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles B, et al.
Hum Pathol
. 2007 Sep;
38(11):1611-20.
PMID: 17868773
We previously reported that reactive stromal grading in radical prostatectomies is a predictor of recurrence and that reactive stromal grading 0 and 3 are associated with lower biochemical recurrence-free survival...
15.
Teh B, Bastasch M, Mai W, Kadmon D, Miles B, Butler E
Am J Clin Oncol
. 2007 Sep;
30(4):395-400.
PMID: 17762440
Purpose: A sural nerve graft may replace a killed cavernosal nerve. The effect of intensity-modulated radiation therapy (IMRT) on function of the graft has not been reported. Materials And Methods:...
16.
Yang G, Addai J, Wheeler T, Frolov A, Miles B, Kadmon D, et al.
Hum Pathol
. 2007 Aug;
38(11):1688-95.
PMID: 17707459
Up-regulation of caveolin-1 (cav-1) has been implicated in human prostate cancer progression/metastasis and shown to promote cancer cell survival. It has also been shown that cav-1 is secreted by tumor...
17.
Kadmon D
Rev Urol
. 2006 Sep;
4(2):87-9.
PMID: 16985660
With a large local tumor, when surgical extirpation results in a positive surgical margin, adjuvant radiotherapy is the routine approach for a variety of solid tumors, such as head and...
18.
Tahir S, Frolov A, Hayes T, Mims M, Miles B, Lerner S, et al.
Clin Cancer Res
. 2006 Aug;
12(16):4872-5.
PMID: 16914574
Purpose: Up-regulation of caveolin-1 (cav-1) is associated with virulent prostate cancer, and serum cav-1 levels are elevated in prostate cancer patients but not in benign prostatic hyperplasia. In this study,...
19.
Teh B, Bastasch M, Mai W, Kattan M, Butler E, Kadmon D
J Urol
. 2006 May;
175(6):2097-101.
PMID: 16697811
Purpose: The benefit of adjuvant radiotherapy after prostatectomy for patients with pathological risk factors but with an undetectable postoperative PSA remains controversial. In this retrospective study we define the benefits...
20.
Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, et al.
Mol Ther
. 2006 Feb;
13(4):716-28.
PMID: 16480930
The limitations of current forms of prostate cancer therapy have driven researchers to search for new alternatives. Previously we showed cytopathic effect related to HSV-tk in prostate cancer. In this...